Rodríguez-Lescure, Á., Gallego, J., García-Alfonso, P., Massuti Sureda, B., Márquez, R., Calvo, L., . . . Haba-Rodriguez, J. d. l. (2024). Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Citación estilo ChicagoRodríguez-Lescure, Álvaro, et al. Hypertension As Predictive Factor for Bevacizumab-containing First-line Therapy in Metastatic Breast and Colorectal Cancer in BRECOL (GEICAM/2011-04) Study. 2024.
Cita MLARodríguez-Lescure, Álvaro, et al. Hypertension As Predictive Factor for Bevacizumab-containing First-line Therapy in Metastatic Breast and Colorectal Cancer in BRECOL (GEICAM/2011-04) Study. 2024.
Precaución: Estas citas no son 100% exactas.